+

ES2164366T3 - Derivados de la distamicina acriloil sustituidos, procedimiento de fabricacion asociado y su utilizacion como agentes antitumorales y antivirales. - Google Patents

Derivados de la distamicina acriloil sustituidos, procedimiento de fabricacion asociado y su utilizacion como agentes antitumorales y antivirales.

Info

Publication number
ES2164366T3
ES2164366T3 ES97937474T ES97937474T ES2164366T3 ES 2164366 T3 ES2164366 T3 ES 2164366T3 ES 97937474 T ES97937474 T ES 97937474T ES 97937474 T ES97937474 T ES 97937474T ES 2164366 T3 ES2164366 T3 ES 2164366T3
Authority
ES
Spain
Prior art keywords
antitumoral
replaced
antiviral agents
distamicina
acriloil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97937474T
Other languages
English (en)
Inventor
Paolo Cozzi
Italo Beria
Giovanni Biasoli
Marina Caldarelli
Laura Capolongo
Cristina Franzetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Application granted granted Critical
Publication of ES2164366T3 publication Critical patent/ES2164366T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A DERIVADOS DE DISTAMICINA SUSTITUIDA POR ACRILOILO REPRESENTADOS POR LA FORMULA (I), DONDE: N ES 2, 3 O 4; R 1 Y R 2 SON SELECCIONADOS, CADA UNO INDEPENDIENTEMENTE, A PARTIR DE HIDROGENO, HALOGENO Y ALQUILO (C 1-4 ); R 3 ES HIDROGENO O HALOGENO; B SE SELECCIONA A PARTIR DE (1), (2), (3), (4), (5), (6) Y (7); DONDE R 4 , R 5 , R 6 , R 7 Y R 8 SON INDEPENDIENTEMENTE CADA UNO, HIDROGENO O ALQUILO(C 1-4 ), CON LA CONDICION DE QUE AL MENOS UNO DE R 4 , R 5 , Y R 6 SEA UN ALQUILO (C 1-4 ) Y A LAS SALES DE DICHOS DERIVADOS FARMACEUTICAMENTE ACEPTABLES. DICHOS COMPUESTOS SON UTILES COMO AGENTES ANTITUMORALES Y ANTIVIRALES.
ES97937474T 1996-07-25 1997-07-10 Derivados de la distamicina acriloil sustituidos, procedimiento de fabricacion asociado y su utilizacion como agentes antitumorales y antivirales. Expired - Lifetime ES2164366T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9615692.2A GB9615692D0 (en) 1996-07-25 1996-07-25 Acryloyl substituted distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents

Publications (1)

Publication Number Publication Date
ES2164366T3 true ES2164366T3 (es) 2002-02-16

Family

ID=10797527

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97937474T Expired - Lifetime ES2164366T3 (es) 1996-07-25 1997-07-10 Derivados de la distamicina acriloil sustituidos, procedimiento de fabricacion asociado y su utilizacion como agentes antitumorales y antivirales.

Country Status (27)

Country Link
US (2) US6482920B1 (es)
EP (1) EP0915845B1 (es)
JP (1) JP4312264B2 (es)
KR (1) KR100408538B1 (es)
CN (1) CN1116281C (es)
AR (1) AR007997A1 (es)
AT (1) ATE205476T1 (es)
AU (1) AU724511B2 (es)
BR (1) BR9710717A (es)
CA (1) CA2260060C (es)
DE (1) DE69706690T2 (es)
DK (1) DK0915845T3 (es)
EA (1) EA001863B1 (es)
ES (1) ES2164366T3 (es)
GB (1) GB9615692D0 (es)
HK (1) HK1020948A1 (es)
HU (1) HU224635B1 (es)
IL (1) IL127689A (es)
MY (1) MY124103A (es)
NO (1) NO310817B1 (es)
NZ (1) NZ334082A (es)
PL (1) PL199865B1 (es)
PT (1) PT915845E (es)
TW (1) TW360652B (es)
UA (1) UA61922C2 (es)
WO (1) WO1998004524A1 (es)
ZA (1) ZA976549B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9806689D0 (en) 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Acryloyl derivatives analogous to distamycin,process for preparing them,and their use as antitumour and antiviral agents
GB9928703D0 (en) * 1999-12-03 2000-02-02 Pharmacia & Upjohn Spa Acryloyl peptidic derivatives,process for their preparation and their use as antitumour agents
US6559125B1 (en) 2000-01-28 2003-05-06 California Institute Of Technology Polyamide-alkylator conjugates and related products and method
PE20011277A1 (es) * 2000-04-14 2002-01-07 Agouron Pharma Compuestos y composiciones antipicornavirales, sus usos farmaceuticos y los materiales para su sintesis
GB0011059D0 (en) 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
GB0015446D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
GB0015444D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and topoisomerase I and II inhibitors
GB0015447D0 (en) * 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
GB0016447D0 (en) 2000-07-04 2000-08-23 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
GB0017852D0 (en) * 2000-07-20 2000-09-06 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
US6576612B1 (en) * 2000-10-02 2003-06-10 Pharmacia Italia S.P.A. Antitumor therapy comprising distamycin derivatives
GB0029004D0 (en) * 2000-11-28 2001-01-10 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
WO2002100852A1 (en) * 2001-06-13 2002-12-19 Genesoft Pharmaceuticals, Inc. Benzothiophene compounds having antiinfective activity
US6969592B2 (en) 2001-09-26 2005-11-29 Pharmacia Italia S.P.A. Method for predicting the sensitivity to chemotherapy
SI1461083T1 (sl) * 2002-01-02 2006-08-31 Nerviano Medical Sciences Srl Kombinirana terapija proti tumorjem na osnovi substituiranih akriloil distamicinskih derivatov in inhibitorjev protein-kinaze (serin/treonin-kinaze)
NZ535700A (en) * 2002-04-02 2007-06-29 Nerviano Medical Sciences Srl Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy
AU2016301745B2 (en) 2015-08-06 2020-07-16 Ube Industries, Ltd. Substituted guanidine derivative
GB202114032D0 (en) * 2021-09-30 2021-11-17 Univ Strathclyde Antivirals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT387013B (de) * 1985-07-16 1988-11-25 Erba Farmitalia Verfahren zur herstellung von poly-4-aminopyrrol -2-carboxamidoderivaten
GB8612218D0 (en) * 1986-05-20 1986-06-25 Erba Farmitalia Site specific alkylating agents
GB8906709D0 (en) * 1989-03-23 1989-05-10 Creighton Andrew M Acryloyl substituted pyrrole derivatives

Also Published As

Publication number Publication date
BR9710717A (pt) 1999-08-17
CN1226232A (zh) 1999-08-18
KR100408538B1 (ko) 2004-01-13
US20030023031A1 (en) 2003-01-30
IL127689A0 (en) 1999-10-28
JP2000515164A (ja) 2000-11-14
PT915845E (pt) 2002-03-28
DK0915845T3 (da) 2002-01-07
AU4009897A (en) 1998-02-20
PL331344A1 (en) 1999-07-05
NO310817B1 (no) 2001-09-03
GB9615692D0 (en) 1996-09-04
HUP9903253A2 (hu) 2000-02-28
HUP9903253A3 (en) 2002-01-28
PL199865B1 (pl) 2008-11-28
JP4312264B2 (ja) 2009-08-12
EA001863B1 (ru) 2001-10-22
DE69706690D1 (de) 2001-10-18
IL127689A (en) 2003-07-31
CA2260060C (en) 2007-01-30
HK1020948A1 (en) 2000-05-26
TW360652B (en) 1999-06-11
NO990246D0 (no) 1999-01-20
CN1116281C (zh) 2003-07-30
CA2260060A1 (en) 1998-02-05
NZ334082A (en) 1999-08-30
EA199900163A1 (ru) 1999-08-26
UA61922C2 (uk) 2003-12-15
EP0915845A1 (en) 1999-05-19
KR20000029448A (ko) 2000-05-25
ZA976549B (en) 1998-02-03
DE69706690T2 (de) 2002-06-20
HU224635B1 (hu) 2005-12-28
ATE205476T1 (de) 2001-09-15
WO1998004524A1 (en) 1998-02-05
US6482920B1 (en) 2002-11-19
EP0915845B1 (en) 2001-09-12
AR007997A1 (es) 1999-11-24
NO990246L (no) 1999-01-20
MY124103A (en) 2006-06-30
AU724511B2 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
ES2164366T3 (es) Derivados de la distamicina acriloil sustituidos, procedimiento de fabricacion asociado y su utilizacion como agentes antitumorales y antivirales.
BR0012243A (pt) Triflúor butenos nematocidas
GT199900055A (es) Nuevas dihidropirimidinas2 heterocìclicamente sustituidas.
ES2179071T3 (es) Agentes vasodilatadores perifericos que comprenden como principio activo derivados de la piperidina 4-amino n-acilada.
AR245700A1 (es) Nuevos derivados de la 2-anilino-pirimidina como agentes antiparasitarios.
ES2036551T3 (es) Compuestos heterociclicos.
ES2053508T3 (es) Compuestos de acidos 3-pirrolidinil-tio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilicos.
ES2160237T3 (es) O-carbamoil-fenilalaninol que tiene sustituyente en anillo de benceno, sus sales farmaceuticamente utiles, y metodo para la preparacion de los mismos.
ES2149468T3 (es) Derivados de radicicol.
BR0008056A (pt) Pirrolocarbazóis e isoindolonas cìclicas fundidas substituìdas
ES2064700T3 (es) Derivados de adenosina con actividad farmaceutica como antihipertensivos.
ES2145267T3 (es) Nuevos derivados bisulfuro de mercaptoacetilamido de 1,3,4,5-tetrahidro-benzo(c)azepin-3-ona utiles como inhibidores de la encefalinasa y del enzima de conversion de la angiotensina.
ES2104015T3 (es) Derivado del acido metoxiiminoacetico y fungicida agricola/horticola que lo contiene como ingrediente activo.
ES2123873T3 (es) Pirrolocarbazol.
ES2084339T3 (es) Tetrahidropiridinas e hidroxipiperidinas sustituidas utiles como agentes para el sistema nervioso central.
ES2159749T3 (es) Derivados de bencilamino-2-metil-propanamidas 2-(4-sustituidas).
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
ES2196614T3 (es) Analogos de la 1-3-dihidroxi-20,20-dialquil-vitamina d3.
DE60013994D1 (de) 1,2-Disubstituierte 1,4-Dihydro-4-oxochinolin-Verbindungen
SE9604582D0 (sv) Novel compounds
DE69206262D1 (de) Oxalon Und Hypotensive 2-Decarboxyl-2 Azylthioalkyl Prostagladin-Derivate.
AR027578A1 (es) Derivados de indano
DK1204658T3 (da) Benzofurylpiperazin-serotoninagonister
AR013836A1 (es) Compuestos espiro [ciclohexil]piperazinilo y composiciones farmaceuticas que los contienen activos como ligandos de un subtipo de receptor de dopamina.
MX9303990A (es) Tetrazolil (fenoxi y fenoxialquil) piperidinil piridazinas como agentes antivirales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 915845

Country of ref document: ES

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载